
Figure 6.
Evaluation of the performance of PepQuery for validating SAAVs in large data sets. (A) Sensitivity and (B) specificity evaluation for validating SAAVs in a large cancer data set. (C) A large proportion of the false positives in B are supported by RNA-seq evidence. (D,E) Two spectra supporting the KRAS G12D mutation in a sample, in which the mutation was supported by DNA but not RNA evidence.











